DCB vs DES, Where is the Limit?

Published: 13 February 2023

  • Views:

    Views Icon 2155

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Drug-coated balloon (DCB) technology permits effective delivery of a drug to a lesion in the arterial wall, but not all DCBs are the same. The Essential pro DCB from iVascular has premium deliverability and last generation nanotechnology TransferTech, proving its reliability.
 
In this series of insightful presentations and discussions, moderator Prof Jose M de la Torre (Cantabria, ES) is joined by Dr Lucio Padilla (Buenos Aires, AR) and Dr Adam Sukiennik (Toruń, PL) to discuss the application and effectiveness of drug-coated balloons vs drug-eluting stents. They highlight the key benefits given by Essential pro and present several clinical cases where its efficacy has been demonstrated.
 
The faculty explore unique components of DCB technology and mechanism of action, explaining in detail the key differentiation between Essential pro and other DCBs, in addition to providing insight into Essential pro application in challenging cases, including bifurcations.
 

This video series is supported by

Learning Objectives

  • When to use a DCB
  • What is important when using a DCB
  • Benefits of using Essential pro

Target Audience

  • Interventional Cardiologists

More from this programme

Part 1

DCB vs DES, Where is the limit? Full Length Video

1 session
DCB vs DES, Where is the limit? Full Length Video Watch now

Part 2

The DCB’s Technology Makes the Difference

1 session
The DCB’s Technology Makes the Difference Watch now

Part 3

Why and How to Use DCBs for ISR?

2 sessions
Why and How to Use DCBs for ISR? (Full Video) Watch now
Why and How to Use DCBs for ISR? (Presentation Only) Watch now

Part 4

DCBs for Provisional Stenting in Bifurcations

1 session
DCBs for Provisional Stenting in Bifurcations Watch now

Part 5

Benefits of DCBs for HBR Patients

1 session
Benefits of DCBs for HBR Patients Watch now

Part 6

The Advantages of a DCB

1 session
The Advantages of a DCB Watch now

About the episode

Prof Jose M de la Torre (Cantabria, ES) delves into the significant benefits of using DCBs in treating patients with high bleeding risk (HBR) and highlights this through two clinical cases. Prof de la Torre has a lot of experience with Essential pro, which has always demonstrated very good results for HBR patients.

Faculty Biographies

José M de la Torre Hernández

José M de la Torre Hernández

Head of Hemodynamics and Interventional Cardiology

Prof Jose M de la Torre is an interventional cardiologist and Head of the Hemodynamics and Interventional Department of the Marques de Valdecilla University of Santander, ES.

Prof Jose M de la Torre is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting in US. Faculty of ESC, PCR, ACC and TCT meetings. Coordinator of the ESTROFA, XIMA and LITRO study groups. 

 

View full profile

Comments

You must be to comment. If you are not registered, you can register here.